330 related articles for article (PubMed ID: 26983668)
1. Dyslipidemia Part 2: Review of Dyslipidemia Treatment in Patients With Noncoronary Vascular Disease.
Gonzalez L; Helkin A; Gahtan V
Vasc Endovascular Surg; 2016 Feb; 50(2):119-35. PubMed ID: 26983668
[TBL] [Abstract][Full Text] [Related]
2. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
Jialal I; Smith G
Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
[No Abstract] [Full Text] [Related]
3. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.
Shapiro MD; Fazio S
Circ Res; 2016 Feb; 118(4):732-49. PubMed ID: 26892970
[TBL] [Abstract][Full Text] [Related]
4. Advances in the treatment of dyslipidemia.
Sabatine MS
Cleve Clin J Med; 2016 Mar; 83(3):181-6. PubMed ID: 26974988
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
[TBL] [Abstract][Full Text] [Related]
6. Atherosclerosis stabilization with PCSK-9 inhibition: An evolving concept for cardiovascular prevention.
Robinson JG; Heistad DD; Fox KA
Atherosclerosis; 2015 Dec; 243(2):593-7. PubMed ID: 26545013
[TBL] [Abstract][Full Text] [Related]
7. Hypolipidemic drugs in elderly subjects: Indications and limits.
Gazzola K; Vigna GB
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1064-1070. PubMed ID: 27522161
[TBL] [Abstract][Full Text] [Related]
8. Clinical controversies in lipid management.
Tziomalos K
Panminerva Med; 2015 Jun; 57(2):65-70. PubMed ID: 25669164
[TBL] [Abstract][Full Text] [Related]
9. Lipid lowering in liver and chronic kidney disease.
Herrick C; Litvin M; Goldberg AC
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):339-52. PubMed ID: 24840263
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention.
Schiele F; Ecarnot F; Chopard R
Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):88-100. PubMed ID: 28618915
[TBL] [Abstract][Full Text] [Related]
11. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.
Stam-Slob MC; Visseren FL; Wouter Jukema J; van der Graaf Y; Poulter NR; Gupta A; Sattar N; Macfarlane PW; Kearney PM; de Craen AJ; Trompet S
Clin Res Cardiol; 2017 Jan; 106(1):58-68. PubMed ID: 27554244
[TBL] [Abstract][Full Text] [Related]
12. Niacin: the evidence, clinical use, and future directions.
Villines TC; Kim AS; Gore RS; Taylor AJ
Curr Atheroscler Rep; 2012 Feb; 14(1):49-59. PubMed ID: 22037771
[TBL] [Abstract][Full Text] [Related]
13. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
[TBL] [Abstract][Full Text] [Related]
14. Novel strategies for managing dyslipidemia: treatment beyond statins.
Ling H; Burns TL; Hilleman DE
Postgrad Med; 2012 Nov; 124(6):43-54. PubMed ID: 23322138
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis.
Lee M; Saver JL; Towfighi A; Chow J; Ovbiagele B
Atherosclerosis; 2011 Aug; 217(2):492-8. PubMed ID: 21592479
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia Part 1--Review of Lipid Metabolism and Vascular Cell Physiology.
Helkin A; Stein JJ; Lin S; Siddiqui S; Maier KG; Gahtan V
Vasc Endovascular Surg; 2016 Feb; 50(2):107-18. PubMed ID: 26983667
[TBL] [Abstract][Full Text] [Related]
17. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
18. PCSK9 inhibition in PAD patients - a rising star in secondary prevention?
Vasa; 2018 Feb; 47(2):157. PubMed ID: 29460708
[No Abstract] [Full Text] [Related]
19. Lipids for psychiatrists - an overview.
Young IS
J Psychopharmacol; 2005 Nov; 19(6 Suppl):66-75. PubMed ID: 16280339
[TBL] [Abstract][Full Text] [Related]
20. [Gastroenterological aspects of atherosclerosis].
Zvenigorodskaia LA; Samsonova NG; Efremov LI; Cherkashova EA; Lazebnik LB
Eksp Klin Gastroenterol; 2011; (2):31-6. PubMed ID: 21560640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
